Overview

• Multiple law firms have filed class action lawsuits against InMode Ltd., alleging securities fraud.
• Investors claim InMode made false statements regarding product pricing and demand.
• Allegations include violations of FDA regulations through off-label marketing and failure to report injuries.
• InMode's stock price plummeted following revelations of routine product discounting and lowered revenue guidance.
• Investors have until April 15, 2024, to join the class action lawsuits and potentially recover losses.